68 filings
8-K
BCYC
Bicycle Therapeutics Plc
18 Jun 24
Other Events
4:18pm
8-K
BCYC
Bicycle Therapeutics Plc
23 May 24
Entry into a Material Definitive Agreement
4:26pm
8-K
BCYC
Bicycle Therapeutics Plc
16 May 24
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
BCYC
Bicycle Therapeutics Plc
2 May 24
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
7:06am
8-K
BCYC
Bicycle Therapeutics Plc
18 Apr 24
Entry into a Material Definitive Agreement
7:00am
8-K
ds8505
20 Feb 24
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
7:05am
8-K
36n8httt84p xs
14 Dec 23
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
7:05am
8-K
sjm9kgs
2 Nov 23
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
7:05am
8-K
y6eksh3mvhkj
11 Sep 23
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
7:05am
8-K
64g29nuzei0hh8gvgd8
3 Aug 23
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:59am
8-K
7ewrff2huaoifv
13 Jul 23
Entry into a Material Definitive Agreement
4:27pm
8-K
f24izh2oxb6
23 Jun 23
Departure of Directors or Certain Officers
7:43am
8-K
8lq3abc ob
14 Jun 23
Submission of Matters to a Vote of Security Holders
8:33am
8-K
i39ashdj1gskb
26 May 23
Other Events
5:26pm
8-K
msafiyq w7
10 May 23
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
7:06am
8-K
c42pguor4pvjscb0
4 May 23
Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:30am
8-K
iaiet7hlmix
3 Apr 23
Bicycle Therapeutics Enhances Leadership Team with Key Appointments
7:05am
8-K
xse81buinx4fz8dn
28 Mar 23
Bicycle Therapeutics Announces a Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates
7:07am
8-K
veft5dj8ai5g
28 Feb 23
Bicycle Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
7:06am
8-K
rfjq9flaxlanlr3
14 Feb 23
Bicycle Therapeutics Announces Phase I Dose Escalation Results from Ongoing Phase I/II Study of BT8009
10:26am